Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Short Interest Update

Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 48,409 shares, an increase of 19.8% from the March 15th total of 40,393 shares. Approximately 6.1% of the shares of the stock are sold short. Based on an average trading volume of 17,704 shares, the short-interest ratio is presently 2.7 days.

Virtus LifeSci Biotech Clinical Trials ETF Stock Performance

NYSEARCA BBC traded up $0.97 on Friday, reaching $47.35. The company had a trading volume of 21,845 shares, compared to its average volume of 21,577. Virtus LifeSci Biotech Clinical Trials ETF has a 12 month low of $16.60 and a 12 month high of $47.81. The firm’s 50 day moving average price is $41.80 and its 200 day moving average price is $37.84.

About Virtus LifeSci Biotech Clinical Trials ETF

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.